tegaserod


Also found in: Wikipedia.

tegaserod

a 5-HT4 receptor partial agonist used to treat irritable bowel syndrome when the primary bowel symptom is constipation.
Mentioned in ?
References in periodicals archive ?
Low-dose nocturnal tegaserod or erythromycin delays symptom recurrence after treatment of irritable bowel syndrome based on presumed bacterial overgrowth.
The Central Drugs Standard Control Organization had also conducted raids in 2011 in and around Delhi and in Mumbai to check the withdrawal of Gatifloxacin, Tegaserod and Rosiglitazone after these drugs were prohibited.
Tegaserod (Zelnorm) has been removed from the market because risks of cardiovascular events were seen in pooled data from 29 short-term clinical studies.
Tegaserod, a drug registered for constipation-predominant IBS, was withdrawn from the market because of cardiac safety concerns.
But promotion to physicians may result in overprescribing and overuse of even mildly effective drugs such as tegaserod before adequate information on their health risk is available," said Dorn.
An advertising campaign for tegaserod (Zelnorm), however, did cause a statistically significant increase in English-speaking areas.
The experimental antibiotic treatment regimen included: rifaximin 1,200 mg day for ten days followed by tegaserod 3 mg, long-term; one month of zinc 220 mg per day; and once-daily probiotic or rifaximin monotherapy.
Prokinetic agents include metoclopramide (also known as Reglan), bethanechol (Duvoid) and tegaserod (Zelnorm).
Tegaserod is a partial 5-HT4 receptor agonist approved for the treatment of constipation-predominant irritable bowel syndrome.
1]gelsesomrENde samt antallet af patienter lader ingen tvivl om, hvor effektiv tegaserod er i behandlingen af irriteret tyktarm med forstoppelse".